Cancer drug breakthrough ‘kicks’ HIV from hiding

Original article by Julia Medew
The Age – Page: 3 : 23-Jul-14

Experts on acquired immunodeficiency syndrome (AIDS) on 22 July 2014 heard from Aarhus University Hospital’s Ole Sogaard at the 20th International AIDS conference in Melbourne. He reported good results in using the romidepsin cancer drug to lure the human immunodeficiency virus (HIV) into a patient’s bloodstream. Once this has occurred, the immune system can attack the HIV cells, if aided by the Vacc-4x experimental vaccine

CORPORATES
UNIVERSITY OF AARHUS|UNIVERSITY OF CALIFORNIA|BIOSANTECH SA

New drug regimen gives hope to millions

Original article by Julia Medew
The Sydney Morning Herald – Page: 7 : 22-Jul-14

A new treatment called PaMZ has been shown to fight tuberculosis (TB) while still allowing anti-retroviral drugs to be used that target the human immunodeficiency virus (HIV). The 20th international congress on the Acquired Immunodeficiency Syndrome (AIDS) in Melbourne on 21 July 2014 heard from Global TB Alliance senior medical officer Daniel Everitt on the promising clinical trials. TB accounts for about 20% of all deaths among those suffering from HIV or AIDS. PaMZ may be widely available from 2018

CORPORATES
GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT